@article {3217,
	title = {The cost of integrated HIV care and buprenorphine/naloxone treatment: results of a cross-site evaluation.},
	journal = {Journal of acquired immune deficiency syndromes (1999)},
	volume = {56 Suppl 1},
	year = {2011},
	month = {2011 Mar 1},
	pages = {S76-82},
	abstract = {Implementing integrated HIV and buprenorphine/naloxone treatment requires cost estimates to plan and obtain funding.},
	keywords = {Anti-HIV Agents, Buprenorphine, Delivery of Health Care, Integrated, Health Care Costs, HIV Infections, Humans, Naloxone, Narcotic Antagonists, Opioid-Related Disorders},
	issn = {1944-7884},
	doi = {10.1097/QAI.0b013e31820a9a66},
	author = {Schackman, Bruce R and Leff, Jared A and Botsko, Michael and Fiellin, David A and Altice, Fredrick L and Korthuis, P Todd and Sohler, Nancy and Weiss, Linda and Egan, James E and Netherland, Julie and Gass, Jonathan and Finkelstein, Ruth}
}
